OPKO Health to Report Third Quarter 2025 Financial Results on October 29

Rhea-AI Summary

OPKO Health (NASDAQ: OPK) will report operating and financial results for the three and nine months ended September 30, 2025 after U.S. market close on Wednesday, October 29, 2025.

Senior management will give a business update and discuss results and financial guidance on a conference call and live audio webcast starting at 4:30 p.m. Eastern on October 29. OPKO encourages pre-registration to receive a unique PIN for immediate access; dial-in options are 833-630-0584 (U.S.) and 412-317-1815 (International). A telephone replay is available until November 5, 2025 (passcode 8678248), and a webcast replay will be posted about one hour after the live call.

MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial markets on Wednesday, October 29, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on October 29^th beginning at 4:30 p.m. Eastern time.

CONFERENCE CALL & WEBCAST INFORMATION

OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relations page and here.

A telephone replay will be available until November 5, 2025, by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 8678248. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com

FAQ

When will OPKO Health (OPK) report Q3 2025 results?

OPKO will report results for the three and nine months ended September 30, 2025 after market close on October 29, 2025.

What time is the OPKO Health (OPK) earnings call on October 29, 2025?

The conference call and webcast begin at 4:30 p.m. Eastern on October 29, 2025.

How can investors join the OPKO Health (OPK) October 29 webcast or call?

Investors can pre-register via the company link to get a PIN or dial 833-630-0584 (U.S.) or 412-317-1815 (International), or access the live webcast on OPKO’s investor relations page.

Will there be a replay of the OPKO Health (OPK) Q3 2025 earnings call?

Yes. Telephone replay is available until November 5, 2025 (passcode 8678248), and a webcast replay will be posted about one hour after the live call.

What will OPKO management discuss on the October 29, 2025 call?

Management will provide a business update, discuss operating and financial results for Q3 2025, and comment on financial guidance.

Can I register for the OPKO Health (OPK) earnings call after it starts on October 29, 2025?

Yes. The company states participants may register at any time, including up to and after the call start time.